Zymenex Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

Zymenex General Information

Description

Provider of research and development of pharmaceutical products. The company develops pharmaceutical products for the treatment of rare, life-threatening, genetic diseases, for which there is no treatment.

Contact Information

Website
www.zymenex.com
Formerly Known As
HemeBiotech
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Roskildevej 12 C
  • 3400 Hillerod
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Chiesi Farmaceutici
Corporate Office
  • Roskildevej 12 C
  • 3400 Hillerod
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zymenex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 26-Aug-2013 Completed Generating Revenue
3. Secondary Transaction - Private Completed Generating Revenue
2. Grant 01-Dec-2007 $15K Completed Generating Revenue
1. Early Stage VC 01-May-2007 Completed Generating Revenue
To view Zymenex’s complete valuation and funding history, request access »

Zymenex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zymenex Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
BankInvest Biotech Ventures Venture Capital Minority
IPCons Corporation Minority
Omega Funds Venture Capital Minority
Sunstone Life Science Ventures Venture Capital Minority
To view Zymenex’s complete investors history, request access »

Zymenex Acquisitions (1)

Zymenex’s most recent deal was a Merger/Acquisition with ACE BioSciences. The deal was made on 09-Nov-2009.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ACE BioSciences 09-Nov-2009 Merger/Acquisition Pharmaceuticals
To view Zymenex’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Zymenex FAQs

  • When was Zymenex founded?

    Zymenex was founded in 1998.

  • Where is Zymenex headquartered?

    Zymenex is headquartered in Hillerod, Denmark.

  • What is the size of Zymenex?

    Zymenex has 50 total employees.

  • What industry is Zymenex in?

    Zymenex’s primary industry is Drug Discovery.

  • Is Zymenex a private or public company?

    Zymenex is a Private company.

  • What is Zymenex’s current revenue?

    The current revenue for Zymenex is .

  • Who are Zymenex’s investors?

    BankInvest Biotech Ventures, IPCons, Omega Funds, and Sunstone Life Science Ventures have invested in Zymenex.

  • When was Zymenex acquired?

    Zymenex was acquired on 26-Aug-2013.

  • Who acquired Zymenex?

    Zymenex was acquired by Chiesi Farmaceutici.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process